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ABSTRACT
Background. Research suggests that low-grade psychotic experiences in the general population are
a common but transitory developmental phenomenon. Using two independent general population
samples, the hypothesis was examined that common, non-clinical developmental expression of
psychosis may become abnormally persistent when synergistically combined with developmental
exposures that may impact on behavioural and neurotransmitter sensitization such as cannabis,
trauma and urbanicity.
Method. The amount of synergism was estimated from the additive statistical interaction between
baseline cannabis use, childhood trauma and urbanicity on the one hand, and baseline psychotic
experiences on the other, in predicting 3-year follow-up psychotic experiences, using data from two
large, longitudinal, random population samples from the Netherlands [The Netherlands Mental
Health Survey and Incidence Study (NEMESIS)] and Germany [The Early Developmental Stages
of Psychopathology (EDSP) study].
Results. The 3-year persistence rates of psychotic experiences were low at 26% in NEMESIS
and 31% in EDSP. However, persistence rates were progressively higher with greater baseline
number of environmental exposures in predicting follow-up psychotic experiences (x2=6.9, df=1,
p=0.009 in NEMESIS and x2=4.2, df=1, p=0.04 in EDSP). Between 21% and 83% (NEMESIS)
and 29% and 51% (EDSP) of the subjects exposed to both environmental exposures and psychotic
experiences at baseline had persistence of psychotic experiences at follow-up because of the syner-
gistic action of the two factors.
Conclusion. The ﬁndings suggest that environmental risks for psychosis act additively, and that
the level of environmental risk combines synergistically with non-clinical developmental expression
of psychosis to cause abnormal persistence and, eventually, need for care.
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INTRODUCTION
Recent lines of evidence suggest an interactive
developmentalmodel of psychosis (Cunningham
Owens & Johnstone, 2006). First, the expression
of psychosis, whether it be psychotic disorders
(prevalence 1%), isolated psychotic symptoms
(prevalence around 5%) or broadly deﬁned
psychotic experiences (prevalence around 15%)
is much more common in young people and
declines with age (Verdoux et al. 1998; Peters
et al. 1999; Van Os et al. 2000; Johns & Van Os,
2001; Myin-Germeys et al. 2003). Second,
follow-up studies of young people with ex-
pression of psychosis at the subclinical level
reveal that the great majority do not display
psychosis at any level at follow-up (Hanssen
et al. 2005). Third, the expression of psychosis
at the subclinical or ‘schizotypal ’ level clusters
in families and is inﬂuenced in part by genetic
factors (Linney et al. 2003; Hanssen et al. 2006).
Finally, the generally good (because the symp-
toms are only transitory) outcome of subclinical
psychotic experiences can be modiﬁed to poorer
outcomes of persistence and clinical need for
care if subjects are exposed to additional (proxy)
environmental risk factors. Examples of these
are trauma (Spauwen et al. 2006b), cannabis
(Van Os et al. 2002; Henquet et al. 2005) and
urbanicity (Van Os et al. 2003, 2004; Spauwen
et al. 2004, 2006a).
The above ﬁndings suggest a model of psy-
chosis that considers genetic background factors
impacting on a broadly distributed and transi-
tory population expression of psychosis during
development, poor prognosis of which, in terms
of persistence and clinical need, is predicted
by environmental exposures interacting with
genetic risk. In other words, transitory devel-
opmental expression of psychosis may become
abnormally persistent and clinically relevant
depending on the degree of environmental risk
the person is additionally exposed to (Fig. 1).
In the current paper, this model was tested
in two separate samples, using measures of
environmental risk combining several likely
environmental exposures. In addition, recent
statistical models of interaction (Darroch, 1997;
Van Os & Sham, 2003) allow for estimation
of the amount of synergy between environ-
mental risks and developmental expression of
psychosis, as an indication of the morbidity




The Netherlands Mental Health Survey and
Incidence Study (NEMESIS)
NEMESIS is a study of the prevalence, in-
cidence, course and consequences of psychiatric
disorders in the Dutch general population.
The overall design of the study is prospective
(3 years), consisting of a T0 baseline survey in
1996, and two follow-up surveys at T1 (assessing
the period between T0 and T1) in 1997, and at
T2 (assessing the period between T1 and T2)
in 1999. A comprehensive description of the
project objectives, sample procedure, response,
diagnostic instruments, quality control pro-
cedures and analyses is provided in previous
publications (Bijl et al. 1998a, b). NEMESIS
is based on a multistage, stratiﬁed, random
sampling procedure, in 90 municipalities. A
sample of private households within each
municipality and members with the most recent
birthday within each household were selected
(Bijl et al. 1998a, b). Subjects were aged 18–64
years and suﬃciently ﬂuent in Dutch to be
interviewed. Individuals living in institutions
were not eligible for interview. A total of 7076
individuals provided informed consent and
were interviewed at T0, representing a response
rate of 69.7%. Previous analyses have shown
that psychopathology had only weak eﬀects
on attrition rate over the follow-up periods
Environmental risk factors















FIG. 1. Development of psychotic disorder : abnormal persistence
( ) of developmental expression of psychosis.
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and was mainly related to failure to locate and
morbidity/mortality rather than refusal (de
Graaf et al. 2000).
The Early Developmental Stages of the
Psychopathology (EDSP) study
The EDSP study (Lieb et al. 2000) collected
data on the prevalence, incidence, risk factors,
co-morbidity and course of mental disorders
in a random, representative population sample
of adolescents and young adults (age range
14–24 years at baseline) in the Munich area
(Germany). The overall design of the study
is prospective (average 42 months), consisting
of a baseline survey (T0, n=3021), three
follow-up surveys (of which only the ﬁrst two
were used in the current paper – T1 and T2)
and a family supplement. Fourteen- to 15-year-
olds were sampled at twice the rate of persons
16–21 years of age, and 22- to 24-year-olds
were sampled at half this rate. Because the
primary goal of the study was to examine
the incidence of psychopathology, the young
group with the presumed highest incidence
density was included at twice the rate and the
oldest group at half the rate. A complete and
detailed description of design, sample, instru-
ments, procedures and statistical methods of
the EDSP is given elsewhere (Wittchen et al.
1998b).
The T0 sample was drawn in 1994 from the
government registries in Munich, Germany, of
registrants expected to be 14–24 years of age
at the time of the T0 interview in 1995. Details
about the sampling and representativeness of
the whole EDSP sample, along with its socio-
demographic characteristics, have been pres-
ented previously (Wittchen et al. 1998b ; Lieb
et al. 2000). A total of 3021 interviews were
completed at T0 (response rate, 71%). The
ﬁrst follow-up study (T1) was conducted
only for respondents aged 14–17 years at T0,
whereas the second follow-up study (T2) was
conducted for all respondents. Of the 3021 re-
spondents of the T0 study, a total of 2548 in-
terviews were completed at T2, which occurred
at an average of 42 months after T0 (response
rate 84%).
For the current report, the risk set consisted
of all respondents with valid data at T0 and T2,
on average 42 months later.
Instruments
NEMESIS
Subjects were interviewed at home by using
the Composite International Diagnostic Inter-
view (CIDI), version 1.1 (Smeets & Dingemans,
1993), at T0 (n=7076), T1 (n=5618) and T2
(n=4848). The CIDI is a structured interview
developed by the World Health Organization
(WHO), and generates diagnoses pertaining
to DSM-III-R (APA, 1994). It was designed
for use by trained interviewers who are not
clinicians. Interviewers read the questions and
recorded the answers of respondents, making
the CIDI essentially a self-report instrument
(Eaton et al. 2000). At T0, the lifetime version of
the CIDI was used. At each of the follow-up
assessments, the CIDI interval version was
applied, which refers to the period of assessment
from the last interview until the present. Data
on the CIDI-G-section about psychosis were
collected at each assessment (T0, T1, T2). At
T0 and T2, telephone clinical reinterviews
were held with individuals endorsing psychotic
experiences as reported previously, to correct
false-positive reports (Van Os et al. 2001;
Hanssen et al. 2005). At T1, no clinical reinter-
views were held, but interviewers were allowed
to probe with clinical follow-up questions if
individuals endorsed psychotic experiences and
discussed these items later with a psychiatrist.
EDSP
Subjects were assessed with the computer-
assisted version of the Munich-CIDI (DIA-X/
M-CIDI; Wittchen & Pﬁster, 1997), an updated
version of the WHO CIDI version 1.2 (WHO,
1990). Diagnostic ﬁndings, according to the
explicit diagnostic criteria of DSM-IV (APA,
1994), were obtained by using the M-CIDI
diagnostic algorithms. Most interviews were
carried out in the homes of the respondents.
The M-CIDI is designed for use by trained
interviewers who are not clinicians and has
high inter-rater reliability and high test–retest
reliability (Wittchen, 1994; Wittchen et al.
1998a). The assessment of psychotic disorders
with CIDI by lay interviewers is not considered
reliable (Anthony et al. 1985). Therefore, in the
EDSP, trained psychologists who were allowed
to probe with follow-up clinical questions
conducted the interviews. At T0, the lifetime
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version of the M-CIDI was used. At each of
the follow-up assessments, the M-CIDI interval
version was applied, which refers to the period
of assessment from the last interview until the
present.
Data on the M-CIDI-G-section about psy-
chosis were only collected at T2, at which time
lifetime ratings of psychotic experiences were
made without diagnostic diﬀerentiation, yield-
ing cumulative incidence data up to the re-
spective age of the respondents at T2.
At T0, and again at T2, participants also
completed the self-report Symptom Checklist-
90-R (SCL-90-R) to screen for a broad range
of psychological problems and symptoms of
psychopathology. The SCL-90-R measures nine
primary symptom dimensions and is designed
to provide an overview of patients’ symptoms
and their severity (i.e. symptoms are scored
dimensionally on a severity scale from 0 to 4) in
the past 2 weeks. The reliability and validity of
the SCL-90-R have been established previously
(Bonicatto et al. 1997; Derogatis, 1977).
Assessment of T0 psychotic experiences
NEMESIS
The CIDI psychosis section (G-section) was
used to measure psychotic experiences at T0.
This section consists of 17 psychosis items con-
cerning delusions (13 items) and hallucinations
(four items) : items G1–G13, G15, G16, G20 and
G21. Each item is scored on a scale of 1–6: 1, no
symptom; 2, psychotic symptom present but
not clinically relevant (not bothered by it and
not seeking help for it) ; 3, symptom is always
the result of substance use; 4, symptom is
always the result of somatic disorders or con-
ditions; 5, true psychotic symptom; 6, inter-
viewer is in doubt because there appears to be
some plausible explanation for what appears
to be a psychotic symptom. ‘Baseline psychotic
experiences ’ was deﬁned as any CIDI rating of
2, 3, 4, 5 or 6 on any of the T0 17 CIDI core
psychosis items.
EDSP
The SCL-90-R subscales ‘Psychoticism’ and
‘Paranoia ’ were used to measure liability for
psychosis at T0. These scales include self-reports
on thought interference, hallucinations and
suspiciousness, and can be regarded, if not as
clear-cut psychotic symptoms, as a subclinical
expression of psychotic experiences (items 7, 8,
16, 18, 35, 43, 62, 68, 76, 77, 83–85, 87, 88, 90).
The T0 ‘Psychoticism’ and ‘Paranoia ’ scales
were combined into one psychosis scale by
adding their scores and dividing the sum by
two as described previously (Henquet et al.
2005). For the purpose of the analyses, ‘baseline
psychotic experiences ’ was a priori deﬁned
dichotomously as the group of individuals with
the highest 10% of scores as described pre-
viously (Henquet et al. 2005).
Assessment of psychosis outcome
NEMESIS
The ratings from the 17 CIDI core psychosis
items on delusions (13 items) and hallucinations
(four items) were used to assess the presence
of psychotic experiences (items G1–G13, G15,
G16, G20, G21). ‘Follow-up psychotic experi-
ences ’ in this study was deﬁned as any CIDI
rating of 2, 3, 4, 5 or 6 on any of the 17 CIDI
psychosis items at T1 or T2.
EDSP
The ratings at T2 from the 15 M-CIDI core
psychosis items on delusions (11 items) and
hallucinations (four items) were used to assess
the presence of psychotic experiences (items
G3–G5, G7–G14, G17, G18, G20, G21) in the
sample. All psychosis items could be rated in
two ways: 0 (no) and 1 (yes). Onset of psychotic
experiences was recorded as within the last
year or before that time. ‘Follow-up psychotic
experiences ’ in EDSP was deﬁned as at least one
positive rating on any of the 15 M-CIDI core
psychosis items.
Assessment of exposure variables
Cannabis exposure
NEMESIS
Consistent with previous work (Van Os et al.
2002), the L-section of CIDI assesses use of
cannabis. Cannabis exposure at T0 was deﬁned
as any lifetime cannabis use.
EDSP
Consistent with previous work (Henquet et al.
2005), the L-section of the M-CIDI assesses use
of cannabis. Cannabis exposure at T0 was de-
ﬁned as lifetime cannabis use of ﬁve times or
more.
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Trauma
NEMESIS
At T0, subjects were asked, using a semi-struc-
tured interview, whether they had experienced
any kind of emotional, physical, psychological
or sexual abuse before age 16 years, providing
an example of each type of trauma. Subjects
answered ‘yes ’ or ‘no’ to each of the questions
and were asked to give an indication about the
frequency on a six-point scale : 1, never ; 2, once;
3, sometimes; 4, regular ; 5, often; 6, very often.
Consistent with previous work (Janssen et al.
2004; Bak et al. 2005), in the analyses, experi-
ence of trauma was a priori dichotomized as
follows: ‘no early trauma’ if the score on any
item was f3 and ‘early trauma’ if the score on
any item was>3.
EDSP
Self-reported lifetime exposure to trauma was
measured in the entire sample using the Post-
traumatic stress disorder (PTSD) and Trauma
module from the CIDI at T0 (Spauwen et al.
2006b). This module started with trauma screen-
ing questions in which respondents could indi-
cate a positive response on a visually presented
list of nine groups of speciﬁed traumatic events
such as ‘experienced physical threat ’, ‘experi-
enced serious accident ’ or ‘being sexually abused
as a child’. A category of ‘any traumatic event’
indicated exposure to any of the nine traumata.
The visual presentation of the list allowed re-
spondents and interviewers to avoid speaking
about sometimes embarrassing and stigmatizing
traumata by simply indicating the number of the
event. Consistent with previous work, aﬃrm-
ative responses to any of the events were labelled
‘self-reported trauma’ (Spauwen et al. 2006b).
Urbanicity exposure
NEMESIS
Consistent with previous work, the original
ﬁve-level classiﬁcation of the urbanization
measure expressed as density of addresses per
km2 (Van Os et al. 2001, 2003) was dichot-
omized as follows: levels 1 (<500), 2 (500–900)
and 3 (1000–1499) were coded as 0 and levels 4
(1500–2499) and 5 (o2500) as 1.
EDSP
Consistent with previous analyses (Spauwen
et al. 2004, 2006a), urbanicity was deﬁned as the
German city of Munich versus the surrounding
areas of Munich. The population density of the
surrounding areas was 553 persons per square
mile and that of the city was 4061 persons per
square mile.
Statistical analyses
All standard errors and tests statistics were
estimated using the software package STATA,
version 9.1 (StataCorp, 2005).
The dependent variable in the analyses was
follow-up psychotic experiences, with environ-
mental risk factors and baseline psychotic ex-
periences as the independent variables. The risk
of persistence of baseline psychotic experiences
was deﬁned as the strength of the association
between baseline psychotic experiences and
follow-up experiences. If the association between
baseline psychotic experiences and follow-up
psychotic experiences is signiﬁcantly diﬀerent
for diﬀerent levels of an environmental exposure
(i.e. there is statistical interaction between base-
line psychotic experiences and an environmental
exposure), there is support for the hypothesis
that this environmental exposure aﬀects the
persistence of baseline psychotic experiences.
For the analyses, the variable ‘environmental
load’ was created. Environmental load was
categorized into four levels : level 0, correspond-
ing to no exposure (neither cannabis nor trauma
nor urbanicity) ; level 1, corresponding to only
one of the three exposures (cannabis or trauma
or urbanicity) ; level 2, corresponding to two of
the three exposures (cannabis and trauma or
cannabis and urbanicity or trauma and urbani-
city) ; and level 3, corresponding to all exposures
(cannabis, trauma and urbanicity).
In line with recent advances in the con-
ceptualization of interaction, we calculated the
statistical additive interaction and estimated
from that the population amount of synergism
between baseline psychotic experiences and
environmental load (Darroch, 1997; Van Os
et al. 2002; Van Os & Sham, 2003). This was
done using the calculations developed by
Darroch (1997) (see Appendix). For these
analyses, a dichotomized measure of environ-
mental load was used (levels 0 and 1 were coded
0 and levels 2 and 3 were coded 1; hereafter :
high environmental load). For all other analy-
ses, including the statistical additive inter-
action, the four-level continuous Environmental
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Load measure was used. To calculate the
statistical interaction under an additive model,
the BINREG procedure in STATA software (Stata-
Corp, 2005) was used, which ﬁts generalized
linear models for the binomial family estimating
risk diﬀerences (risk diﬀerence regression).
Main eﬀects were thus expressed on the additive
scale (i.e. as a risk diﬀerence rather than a risk
ratio). Estimates for risk diﬀerences were
a priori adjusted for age, sex, educational level
and any T0 CIDI lifetime DSM-III-R diagnosis.
Interactions between environmental load and
baseline psychotic experiences were ﬁtted in
the risk set of both NEMESIS and EDSP with
environmental load entered both as a linear
variable and as dummy variables with category
0 as the reference category, allowing estimation
of baseline psychotic experiences eﬀect sizes for
each level of environmental load separately by
calculating the appropriate linear combinations
using the STATA LINCOM routine.
Risk set
NEMESIS
All the analyses were conducted in the group of
individuals who had completed the CIDI psy-
chosis G-section at T0 (7075 of 7076 subjects,
99.9%), whose cannabis, trauma and urban ex-
posures were documented (n=7055) and who
had completed the CIDI psychosis G-section at
T1 and T2 (n=4792), yielding a risk set of 4786.
EDSP
All the analyses were conducted in the group of
individuals who had completed the SCL-90-R
subscales ‘Psychoticism’ and ‘Paranoia’ at T0
(3013 of 3021 subjects, 99.7%), whose cannabis,
trauma and urban exposures at T0 were docu-
mented (n=2926) and who had completed the
M-CIDI psychosis G-section at T2, yielding a
risk set of 2452.
Sensitivity analysis
In accordance with previous work conducted
in the EDSP study sample (Spauwen et al. 2003,
2004), a sensitivity analysis was used in the
EDSP risk set, to ensure that current ﬁndings
relate only to prediction of incident psychotic
experiences assessed with the M-CIDI. Thus,
subjects who had reported psychotic experiences
according to the M-CIDI at follow-up with
onset longer than 1 year ago were excluded from
the sensitivity analysis, thus ensuring that
psychotic experiences reported at follow-up were
not the same as those reported at baseline.
RESULTS
Subjects
In the risk set of 4786 subjects in the NEMESIS
cohort, subjects were older than the 2452 sub-
jects in the risk set of the EDSP cohort. Other
diﬀerences related to demographic and instru-
ment diﬀerences are depicted in Table 1. Of
the 768 individuals with baseline psychotic
experiences in NEMESIS, follow-up psychotic
experiences were present in 200 (26%). Of the
229 individuals with baseline psychotic experi-
ences in EDSP, follow-up psychotic experiences
were present in 71 (31%).
Synergism between baseline psychotic
experiences and environmental load
NEMESIS
The rate of follow-up psychotic experiences in
the eight exposure levels deﬁned by baseline
psychotic experiences and environmental load
are depicted in Table 2. For each level of ex-
posure, the risk of having follow-up psychotic
experiences was higher in subjects with base-
line psychotic experiences than in the subjects
without baseline psychotic experiences. The risk
diﬀerences, i.e. the diﬀerence between the risk of
having follow-up psychotic experiences in the
groups with and without baseline psychotic ex-
periences, separately for each level of environ-
mental load, revealed that the association with
follow-up psychotic experiences became pro-
gressively stronger as the level of environmental
load went up. The risk diﬀerence eﬀect size in-
creased from 18.2% for unexposed subjects
(environmental load ‘0’), to 33.9% for subjects
exposed to all environmental factors (environ-
mental load ‘3’). These diﬀerences in eﬀect size
were signiﬁcant, as evidenced by a signiﬁcant
positive interaction between environmental load
and baseline psychotic experiences (Wald
x2=6.9, df=1, p=0.009). This interaction
changed only minimally after adjustment for
age, sex, educational level and any T0 diagnosis
(Wald x2=6.6, df=1, p=0.01).
The risk of follow-up psychotic experiences,
in the group with neither baseline psychotic
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experiences nor high environmental load (the
dichotomized measure of environmental load
as deﬁned in Method section) was 2.6% (95 of
3688). For the group exposed to high environ-
mental load alone, this was 5.8% (19 of 330),
23.6% (139/589) for those exposed to baseline
psychotic experiences alone, rising to 34.1%
(61/179) in those exposed to both baseline
psychotic experiences and high environmental
load. Following the procedure developed by
Darroch (1997) (see also formulas and tables
in the Appendix), the proportion of individuals
with follow-up psychotic experiences at T2
exposed to both baseline psychotic experiences
and high environmental load that was attribu-
table to the synergistic action of these factors
Table 1. Characteristics of subjects at T0, T0 exposure, baseline psychotic experiences and follow-up
psychotic experiences, the Netherlands Mental Health Survey and Incidence Study (NEMESIS) and
the Early Developmental Stages of Psychopathology study (EDSP)
NEMESIS (n=4786) EDSP (n=2452)
n % n %
T0
Age (years) 41.02 11.9 (18–64) 18.3 3.3 (13–25)
Gender
Male 2227 46.5 1256 51.2
Female 2559 53.5 1196 48.8
Level of educationa
1 1434 30.3 298 12.2
2 1752 37.1 738 30.1
3 363 7.7 1416 57.8
4 1178 24.9 N.A. N.A.
Any T0 DSM diagnosisb
No 2880 60.2 1361 55.5
Yes 1906 39.8 1091 44.5
Exposure status
Baseline psychotic experiencesc
No 4018 83.9 2223 90.7
Yes 768 16.1 229 9.3
Cannabis
No use 4341 90.7 2131 86.8
Any use 445 9.3 321 13.2
Trauma
Non-exposed 4157 86.9 1970 80.3
Exposed 629 13.1 482 19.7
Urbanization
Rural 2998 62.4 728 29.7
Urban 1798 37.5 1724 70.3
Environmental loadd
Zero 2482 51.9 539 22.0
One 1785 37.5 1386 56.5
Two 450 9.4 440 17.9
Three 59 1.2 87 3.6
T2
Follow-up psychotic experiencese
No 4472 93.4 2026 82.6
Yes 314 6.6 426 17.4
N.A., Not applicable.
a NEMESIS: 1=primary, basic vocational, 2=lower secondary, 3=higher secondary, 4=higher professional university. EDSP: 1=low,
2=medium, 3=high.
b NEMESIS: T0 any DSM-III-R diagnosis. EDSP: T0 any DSM-IV diagnosis.
c NEMESIS: any Composite International Diagnostic Interview (CIDI) rating of 2, 3, 4, 5 or 6 on any of the T0 17 CIDI core psychosis
items. EDSP: deﬁned dichotomously as the group of individuals with the highest 10% of Symptom Checklist-90-R (SCL-90-R) scores.
d Zero=no exposure ; one=subjects exposed to only one of the three exposures; two=subjects exposed to two of the three exposures;
three=subjects exposed to all exposures.
e NEMESIS: any CIDI rating of 2, 3, 4, 5 or 6 on any of the 17 CIDI psychosis items at T1 or T2. EDSP: at least one positive rating
on any of the 15 M-CIDI core psychosis items at T2.
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was calculated. This calculation yielded ﬁgures
for synergism between 0.073 and 0.283, rep-
resenting respectively 21% and 83% of the
psychosis risk in those exposed to both baseline
psychotic experiences and high environmental
load (0.073/0.341=21% and 0.283/0.341=
83%). In other words, an estimated 21–83% of
the individuals exposed at baseline to both
baseline psychotic experiences and at least two
of the environmental risk factors under exam-
ination had persistence of psychotic experiences
at follow-up because of the synergistic action of
the two factors.
EDSP
The rates of follow-up psychotic experiences in
the eight exposures states are depicted in Table
3. The risk diﬀerence eﬀect size increased from
8.3% for unexposed subjects, to 37.9% for
subjects exposed to all three environmental risk
factors. Again a signiﬁcant positive interaction
was evident between environmental load and
baseline psychotic experiences (Wald x2=4.2,
df=1, p=0.04). This interaction was not re-
duced after adjustment for age, sex, educational
level and any T0 diagnosis (Wald x2=5.3, df=1,
p=0.02). In the sensitivity analysis, the results
similarly did not change after the exclusion of
subjects presenting with an onset of psychotic
experiences, according to the M-CIDI, more
than 1 year ago (Wald x2=4.2, df=1, p=0.04).
The risk of follow-up psychotic experiences was
14.8% in subjects exposed to neither baseline
psychotic experiences nor high environmental
load, 24.5% in those exposed to high environ-
mental load alone, 20.7% in those exposed to
baseline psychotic experiences alone, and
42.7% for those exposed to both baseline psy-
chotic experiences and high environmental
load. Filling in these risks in the formulas by
Darroch (1997) revealed that between 29% and
51% of the individuals exposed to both baseline
psychotic experiences and high environmental
load had persistence of baseline psychotic
experiences because of the synergistic action of
these two factors.
DISCUSSION
To our knowledge, this is the ﬁrst study that
examined and replicated possible synergism
between continuous developmental environ-
mental load and psychotic experiences in pre-
dicting the minority of individuals who will
display persistence of psychosis experiences. The
two analyses presented replicated the ﬁnding
Table 2. Interaction between baseline psychotic experiences and environmental load on the additive
























(%) 95% CI p
Zero No 43 2161 1.9 18.2 13.4–22.9 0.000
Yes 56 222 20.1
One No 52 1432 3.5 23.1 18.2–28.1 0.000
Yes 83 228 26.7
Two No 14 285 4.7 26.4 18.6–34.2 0.000
Yes 47 104 31.1
Three No 5 26 16.1 33.9 11.3–56.5 0.003
Yes 14 14 50.0
Additive interactiond x2=6.9 df=1 0.004
CI, Conﬁdence interval ; df, degrees of freedom.
a Zero=no exposure; one=subjects exposed to only one of the three exposures ; two=subjects exposed to two of the three exposures ;
three=subjects exposed to all exposures.
b Any Composite International Diagnostic Interview (CIDI) rating of 2, 3, 4, 5 or 6 on any of the T0 17 CIDI core psychosis items.
c Any CIDI rating of 2, 3, 4, 5 or 6 on any of the 17 CIDI psychosis items at T1 or T2.
d Test for signiﬁcant diﬀerence in increase in risk with one unit change in exposure rating between group with and without psychotic
experiences.
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that the probability of persistence of psychotic
experiences was substantially greater in subjects
exposed to all three environmental exposures
compared to those with a lesser degree of ex-
posure. Between 21% and 83% (NEMESIS),
and 29% and 51% (EDSP), of the subjects ex-
posed to both environmental exposures and
psychotic experiences at T0 had persistence of
expression of psychosis at follow-up because of
the synergistic action of the two causes. These
ﬁndings suggest that (i) the eﬀect of diﬀerent
environmental risk factors for psychosis is
additive, and (ii) if the environmental load were
reduced, the prognosis of developmental ex-
pression of psychosis in the general population
could be modiﬁed considerably, assuming caus-
ality.
In accordance with previous studies that
examined associations with each environmental
factor separately (cannabis use, trauma and
urbanicity) (Van Os et al. 2002; Spauwen et al.
2004, 2006a, b ; Van Os, 2004; Henquet et al.
2005), this triad of exposures may impact on risk
for psychotic disorder by causing an abnormal
persistence of a developmentally common ex-
pression of psychotic experiences, reﬂecting a
plausible mechanism by which these risk factors
may increase the risk for psychotic disorder.
In addition, the environmental risk factors act
additively in increasing the risk for persistence
of psychotic experiences; the separate associ-
ations with each risk factor become a joint
strong eﬀect (Van Os et al. 2005b). Thus, under
the inﬂuence of these three environmental
factors, the ﬁrst phase of the onset of psychotic
disorder may be construed as the abnormal
persistence and deterioration of a distributed
developmental expression of psychosis.
Analytical models of persistence of psychosis
The central question of the analysis was per-
sistence of psychotic experiences from baseline
to follow-up. Analytically, this was tested using
an interaction between baseline psychotic ex-
periences and environmental load in the model
of follow-up psychotic experiences. This model,
however, assumes that environmental load
does not increase the risk of baseline psychotic
experiences (i.e. the variables making up the
interaction are independent). If environmental
load increases the risk for baseline psychotic
experiences, the analysis cannot distinguish be-
tween a model of environmental load causing
poor prognosis of prevalent psychotic experi-
ences, and a model of environmental load
causing incident poor prognosis psychotic ex-
periences. In practice, however, the distinction
between these two is academic, and in fact for
Table 3. Interaction between psychotic experiences and environmental load on the additive scale
























(%) 95% CI p
Zero No 66 427 13.4 8.3 x3.9 to 20.6 0.2
Yes 10 36 21.7
One No 197 1088 15.3 10.4 1.7 to 19.2 0.02
Yes 26 75 25.7
Two No 76 300 20.2 17.3 4.7 to 29.8 0.007
Yes 24 40 37.5
Three No 16 53 23.2 37.9 13.3 to 62.5 0.003
Yes 11 7 61.1
Additive interactiond x2=4.2 df=1 0.04
CI, Conﬁdence interval ; df, degrees of freedom.
a Zero=no exposure ; one=subjects exposed to only one of the three exposures; two=subjects exposed to two of the three exposures;
three=subjects exposed to at all exposures.
b Deﬁned dichotomously as the group of individuals with the highest 10% of Symptom Checklist-90-R (SCL-90-R) scores.
c At least one positive rating on any of the 15 Munich-Composite International Diagnostic Interview (M-CIDI) core psychosis items at T2.
d Test for signiﬁcant diﬀerence in increase in risk with one unit change in exposure rating between group with and without psychotic
experiences.
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most environmental exposure in psychiatry
both mechanisms are likely to be true (Van Os
et al. 2005a). Thus, a post-hoc analysis revealed
that high environmental load was associated
with baseline psychotic experiences in both
NEMESIS [odds ratio (OR) 1.95, 95% conﬁ-
dence interval (CI) 1.79–2.14, p<0.01] and
EDSP (OR 1.49, 95% CI 1.25–1.78, p<0.01).
Similarly, several risk factors for psychosis are
associated not only with incidence, but also with
persistence (Van Os et al. 1997, 1998). Thus,
cannabis is associated not only with onset, but
also with poor prognosis of psychotic illness
(Grech et al. 2005).
Possible mechanism of risk
A hypothesis of a causal mechanism may reside
in the more direct and indirect eﬀects of canna-
bis, trauma and urbanicity during development,
on what has been called dopamine sensitization
(Laruelle, 2000; Howes et al. 2004). Thus,
cannabis may have a direct developmental im-
pact on dopamine sensitization. The primary
active constituent of cannabis is delta-9-tetra-
hydrocannabinol (THC), aﬀecting in particular
the cannabinoid CB1 receptor in the brain
(Freund et al. 2003; Howlett et al. 2004). The
use of cannabis activates the CB1 receptor with
a net eﬀect of increased dopamine release in
the limbic system (Cheer et al. 2004). Studies
conducted in rats and human have suggested
that puberty and adolescence are vulnerable
periods with regard to THC exposure
(Arseneault et al. 2002; Schneider & Koch,
2003; Henquet et al. 2005). Repeated exposure
to cannabis may lead to prolonged changes in
the functioning of the dopamine system, and
eventually dopamine sensitization (Henquet
et al. 2005). These changes may be more im-
portant for subjects with a pre-existing vulner-
ability to dysregulation of the cannabinoid and
related neurotransmitter systems (Caspi et al.
2005; Dean & Murray, 2005; Henquet et al.
2005, 2006).
Recent studies have reported that neurotoxi-
city may be on the pathway between childhood
trauma and schizophrenia supporting the trau-
matogenic neurodevelopmental (TN) model
(Walker & Diforio, 1997). In this model, child-
hood trauma may lead to neurodevelopmental
abnormalities and particularly produce perma-
nent damage in the stress regulation mechanism
in the hypothalamic–pituitary–adrenal (HPA)
axis (Bremner, 2005). The persistence of ex-
position to stressors and the chronicity of
heightened glucocorticoid release, can induce
permanent changes in the HPA axis and,
through this, aﬀect the dopamine system
(Walker & Diforio, 1997). Thus, exposure to
stressors increases both cortisol release and
dopamine, the latter being known as a neuro-
transmitter associated with the expression of
psychosis (Kapur, 2003). It has been suggested
that dopamine plays an important role by
mediating the ‘salience ’ of environmental events
and internal representations (Berridge &
Robinson, 1998; Waelti et al. 2001). Schizo-
phrenia may be associated with endogenous
dopamine sensitization, a state characterized by
hyper-responsiveness of dopamine neurons to
environmental stimuli, in which even exposure
to moderate levels of stress is associated with
excessive dopamine (Lieberman et al. 1990;
Duncan et al. 1999; Laruelle & Abi-Dargham,
1999; Laruelle et al. 1999). Thus, a dysregu-
lated, hyperdopaminergic state may lead to
stimulus-independent dopamine release, which
may take over the normal process of contex-
tually driven salience attribution and then lead
to aberrant assignment of salience to external
objects and internal representations during the
acute phase of psychosis (Kapur, 2003). In line
with this, studies have reported that dopamine
mediates the expression of psychotic experiences
in patients with schizophrenia (Marcelis et al.
2004; Myin-Germeys et al. 2005a, b).
The mechanism of behavioural or neuro-
chemical sensitization may be involved in a com-
parable way for the developmental exposure
referred to as ‘urbanicity’, reﬂecting in all like-
lihood an environmental exposure in urban
environments. Growing up in an urban en-
vironment may increase the risk for people to be
exposed to environmental stresses such as viol-
ence and victimization, social isolation and pol-
lution rather than selection (Marcelis et al. 1998;
Verheij et al. 1998; Pedersen & Mortensen,
2001). Stressful environments might also give
rise to behavioural sensitization as a reﬂection
of dopamine sensitization (Myin-Germeys et al.
2005a, b).
Thus, cumulative exposure to these additively
acting developmental environmental risk fac-
tors in subjects with liability for psychosis, as
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evidenced by psychotic experiences may result
in cumulative changes in the functioning of
the dopamine system, possibly aﬀecting the
persistence and deterioration of developmental
psychotic features.
Methodological issues
Persistence of psychotic experiences and
transition to psychotic disorder
In the NEMESIS and EDSP datasets, the psy-
chotic experiences at follow-up were assessed
respectively with the CIDI and the M-CIDI,
which are very close conceptually and logis-
tically. Psychotic experiences are much more
prevalent than psychotic disorders and the ques-
tion arises as to what degree they reﬂect the
same underlying phenotype. Research suggests
that psychotic experiences reﬂect the lower end
of a continuum, with more severe states such
as schizophrenia at the highest end (Kendler
et al. 1993; Chapman et al. 1994; Poulton et al.
2000; Van Os et al. 2000, 2001; Johns & Van Os,
2001). Previous studies have shown that the
environmental and genetic risk factors for
schizophrenia, including the environmental risk
factors examined in this study, have an impact
on the occurrence of both clinical psychotic
disorder and subclinical psychotic experiences
(Verdoux et al. 1998; Johns & Van Os, 2001;
Van Os & Jones, 2001; Van Os et al. 2001,
2002; Krabbendam et al. 2002; Spauwen et al.
2003; Janssen et al. 2004; Henquet et al. 2005).
As transition from a subclinical state to a clini-
cal disorder necessarily involves a degree of
persistence and subsequent deterioration, our
ﬁndings suggest that exposure to the three
environmental risk factors inﬂuences not only
the persistence of psychotic experiences but also,
through this, the emergence of psychotic dis-
order. However, further research is needed to
examine whether and how persistence of psy-
chotic experience leads to the development of
need for care and a diagnosable disorder.
Baseline psychotic experiences at T0
The SCL-90-R was used to measure psychotic
experiences at T0 in EDSP. The fact that this
instrument covers only the past 2 weeks may
have led to an underestimation of the true
positives at T0. Nevertheless, the repercussions
of this misclassiﬁcation would only be a decrease
in risk diﬀerences between groups, and is thus
unlikely to result in spurious ﬁndings. The
validity of the measure of psychotic experiences
by a self-report instrument may be questionable.
However, a recent study demonstrated the val-
idity of the assessment of psychotic experiences
by self-report in a general population sample
(Konings et al. 2006), and the longitudinal
validity of self-reported psychotic experiences
in population samples has also been established
(Poulton et al. 2000; Hanssen et al. 2005).
Psychotic experiences at T2
The CIDI and M-CIDI were used in the
NEMESIS and EDSP studies respectively to
measure psychotic experiences at follow-up. The
limitation of the CIDI is that this instrument
is not considered reliable to assess psychotic
disorders by lay interviewers (Anthony et al.
1985). However, subjects were assessed by face-
to-face interview, which may have yielded better
results than a self-report questionnaire. In ad-
dition, clinical reinterviews were conducted in
both NEMESIS and EDSP, the psychologists
who conducted the interviews were allowed to
probe with follow-up questions, thus making
the interview clinical rather than self-report
(Spauwen et al. 2006b).
APPENDIX
Estimation of the amount of biological
synergism between baseline psychotic
experiences and environmental load
(see Darroch, 1997; Van Os et al. 2002;
Van Os & Sham, 2003)
To quantify the extent to which (proxy) genetic
risk and environmental factors act synergisti-
cally in disease causation, we have to consider
the population that has developed psychosis
after exposure to both (proxy) genetic and en-
vironmental risk factors, taking into account the
possibility that among those subjects some of
them would have developed psychosis after the
exposure to either (proxy) genetic risk or
environmental risk alone, which refers to paral-
lelism (Darroch, 1997; Van Os et al. 2002; Van
Os & Sham, 2003). If there is parallelism (proxy)
genetic and environmental risks are competitive
in causing psychosis. Thus, if the proportion
of subjects that develops psychosis because the
Psychosis proneness – psychosis persistence 523
co-participation of (proxy) genetic risk and
environmental risk decreases, there is more
competition between both risk factors. It is not
possible to calculate the amount of synergy
and the amount of parallelism in subjects ex-
posed to both (proxy) genetic liability and en-
vironmental exposure. However, the estimation
of the amount of biological synergism can be
approximated, in part, from the calculation of
which synergism exceeds parallelism (Darroch,
1997; Van Os et al. 2002; Van Os & Sham,
2003).
To calculate this excess of synergism, we use
the risk eﬀects associated with the four exposure
states. For illustration, the table of risk eﬀects





















The risk of having follow-up psychotic
experiences in the group exposed to neither
psychotic experiences nor more than one
environmental exposure was 2.6% (95/3688).
The risks in those only exposed to psychotic
experiences and no or one environmental risk
factor was 5.8% (19/330), in those exposed to
environmental exposures alone 23.6% (139/
589), and the risk in those exposed to both fac-
tors 34.1% (61/179).
The excess of the combined eﬀects of (proxy)
genetic and environmental risk over the sum of
their solitary eﬀects is the eﬀect associated with
the combined exposure to (proxy) genetic and
environmental risk minus the eﬀect associated
with the exposure to (proxy) genetic risk alone
and minus the eﬀect associated with environ-
mental risk alone. The amount by which syner-
gism exceeds parallelism equals the excess of the
combined eﬀect of (proxy) genetic risk and en-
vironmental risk over the sum of the solitary
eﬀects of (proxy) genetic risk and environmental
risk, which is the statistical additive interaction




If synergism is positive, then the statistical ad-
ditive interaction is positive, if synergism is
equal to zero, the statistical additive interaction
is inferior or equal to zero.
For example, ﬁlling in the risks of the
NEMESIS study in the previous formula:
[R(GE)xR(G)xR(E)+R]
=0341x0058x0236+0026=0073
The statistical additive interaction is positive
(0.073), indicating that baseline psychotic ex-
periences and environmental load interact on
the additive scale.
The next step is to ﬁll these risks in, in the


































Synergism was between 0.073 and 0.283, which
represents respectively 21% and 83% of the
psychosis risk in those exposed to both psy-
chotic experiences and environmental load
(0.073/0.341=21% and 0.283/0.341=83%).
Thus, an estimated 21% to 83% of subjects
exposed to both exposures and baseline psy-
chotic experiences had follow-up psychotic ex-
periences because of the synergistic action of the
two causes.
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